2-(2H-1,2,3-triazol-2-yl)ethanaminehcl
95%
- Product Code: 62314
CAS:
4320-99-4
| Molecular Weight: | 148.59 g./mol | Molecular Formula: | C₄H₉ClN₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28125978 | |
| Melting Point: | 171-172 °C | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in pharmaceutical research and development due to its potential as a building block in the synthesis of biologically active molecules. Its triazole moiety is particularly valuable in drug design, as it can enhance binding affinity and metabolic stability in target compounds. It is often employed in the creation of small molecule inhibitors, which can be used to modulate specific enzymes or receptors involved in various diseases. Additionally, it finds application in the development of antimicrobial agents, as the triazole ring structure is known to exhibit significant activity against a range of pathogens. In medicinal chemistry, it is also used to optimize pharmacokinetic properties of drug candidates, improving their efficacy and safety profiles.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿18,000.00 |
+
-
|
| 0.250 | 10-20 days | ฿31,500.00 |
+
-
|
2-(2H-1,2,3-triazol-2-yl)ethanaminehcl
This compound is primarily utilized in pharmaceutical research and development due to its potential as a building block in the synthesis of biologically active molecules. Its triazole moiety is particularly valuable in drug design, as it can enhance binding affinity and metabolic stability in target compounds. It is often employed in the creation of small molecule inhibitors, which can be used to modulate specific enzymes or receptors involved in various diseases. Additionally, it finds application in the development of antimicrobial agents, as the triazole ring structure is known to exhibit significant activity against a range of pathogens. In medicinal chemistry, it is also used to optimize pharmacokinetic properties of drug candidates, improving their efficacy and safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :